Andreas H. Scheel

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer.

Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer.

Journal: Archives of pathology & laboratory medicine

Published: July 08, 2024

Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer.

Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer.

Journal: Histology and histopathology

Published: March 26, 2024

Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.

Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.

Journal: NPJ precision oncology

Published: March 18, 2024

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 25, 2023

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Journal: The Journal of clinical investigation

Published: March 07, 2023

KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.

KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 14, 2023

Evolutionary trajectories of small cell lung cancer under therapy.

Evolutionary trajectories of small cell lung cancer under therapy.

Journal: Nature

Published: January 25, 2023

Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing.

Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing.

Journal: Scientific reports

Published: September 25, 2022

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 03, 2022

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.

Journal: Cancers

Published: March 10, 2022

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 28, 2022

Title Not Found

Title Not Found

Journal: Der Pathologe

Published: August 24, 2021

Showing 1-12 of 58

Last Updated: 09/26/2026